Literature DB >> 12948431

Impact of the obesity epidemic on hypertension and renal disease.

John E Hall1, Daniel W Jones, Jay J Kuo, Alexandre da Silva, Lakshmi S Tallam, Jiankang Liu.   

Abstract

Excess weight gain is a major cause of increased blood pressure in most patients with essential hypertension, and also greatly increases the risk for renal disease. Obesity raises blood pressure by increasing renal tubular reabsorption, impairing pressure natriuresis, causing volume expansion due to activation of the sympathetic nervous system and renin-angiotensin system, and by physical compression of the kidneys, especially when visceral obesity is present. The mechanisms of sympathetic nervous system activation in obesity may be due, in part, to hyperleptinemia that stimulates the hypothalamic pro-opiomelanocortin pathway. With prolonged obesity, there may be a gradual loss of nephron function that worsens with time and exacerbates hypertension. Weight reduction is an essential first step in the management of obesity hypertension and renal disease. Special considerations for the obese patient, in addition to adequately controlling the blood pressure, include correction of the metabolic abnormalities and protection of the kidneys from further injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948431     DOI: 10.1007/s11906-003-0084-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  47 in total

Review 1.  What can we do about the "epidemic" of obesity.

Authors:  John E Hall; Daniel W Jones
Journal:  Am J Hypertens       Date:  2002-07       Impact factor: 2.689

2.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

Authors:  W G Haynes; D A Morgan; A Djalali; W I Sivitz; A L Mark
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

3.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

Authors:  Edgar R Miller; Thomas P Erlinger; Deborah R Young; Megan Jehn; Jeanne Charleston; Donna Rhodes; Sharmeel K Wasan; Lawrence J Appel
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  Oxidative stress in a rat model of obesity-induced hypertension.

Authors:  A D Dobrian; M J Davies; S D Schriver; T J Lauterio; R L Prewitt
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

6.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

7.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.

Authors:  M Praga; E Hernández; J C Herrero; E Morales; Y Revilla; R Díaz-González; J L Rodicio
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

8.  Blood pressure is associated with body mass index in both normal and obese children.

Authors:  Q He; Z Y Ding; D Y Fong; J Karlberg
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

9.  Prevalence and trends in overweight among US children and adolescents, 1999-2000.

Authors:  Cynthia L Ogden; Katherine M Flegal; Margaret D Carroll; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

10.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.

Authors:  G Assmann; H Schulte
Journal:  Am Heart J       Date:  1988-12       Impact factor: 4.749

View more
  25 in total

1.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

2.  Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice.

Authors:  Lusha Xiang; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

3.  Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy.

Authors:  Tao Wang; Yan Zhang; Ning Wang; Qiong Liu; ZeKai Wang; Bing Liu; Kai Niu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

4.  Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia
Journal:  J Clin Endocrinol Metab       Date:  2012-02-29       Impact factor: 5.958

Review 5.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

6.  Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.

Authors:  Quaisar Ali; Sanket Patel; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-08

Review 7.  Nonpharmacologic therapy for hypertension: does it really work?

Authors:  Thor Tejada; Alessia Fornoni; Oliver Lenz; Barry J Materson
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

8.  Progression is accelerated from prehypertension to hypertension in blacks.

Authors:  Anbesaw Selassie; C Shaun Wagner; Marilyn L Laken; M LaFrance Ferguson; Keith C Ferdinand; Brent M Egan
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

9.  Renal denervation abolishes the age-dependent increase in blood pressure in female intrauterine growth-restricted rats at 12 months of age.

Authors:  Suttira Intapad; F Lee Tull; Andrew D Brown; John Henry Dasinger; Norma B Ojeda; Joel M Fahling; Barbara T Alexander
Journal:  Hypertension       Date:  2013-02-19       Impact factor: 10.190

Review 10.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.